Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 70
Filter
4.
Nervenarzt ; 72(10): 770-81, 2001 Oct.
Article in German | MEDLINE | ID: mdl-11688178

ABSTRACT

UNLABELLED: The aim of the study was to analyze the results of stereotactic radiotherapy using a linear accelerator in patients with brain metastases. We quantified the following clinical parameters: tumor response and tumor control after therapy, survival, and side effects. Results of the treatment were compared with those from traditional treatment strategies such as surgery and whole brain irradiation. Sixty patients with brain metastases (80 lesions, 36 men and 24 women, mean age 57 years) were treated with stereotactic radiotherapy. The mean follow-up time was 13 months. CONCLUSION: Stereotactic radiotherapy is an important option in the treatment strategy for patients with brain metastases. In comparison to whole brain irradiation, stereotactic radiotherapy achieved a higher local tumor control with a lower rate of side effects. In comparison to surgery, stereotactic radiotherapy has the advantages of shorter treatment time and lower treatment-related morbidity and mortality.


Subject(s)
Brain Neoplasms/radiotherapy , Brain/radiation effects , Dose Fractionation, Radiation , Radiosurgery/methods , Adult , Aged , Aged, 80 and over , Brain/pathology , Brain Neoplasms/secondary , Disease-Free Survival , Dose-Response Relationship, Radiation , Female , Humans , Karnofsky Performance Status , Male , Middle Aged , Prospective Studies , Radiosurgery/adverse effects , Survival Analysis , Treatment Outcome
5.
Strahlenther Onkol ; 177(9): 462-8, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11591019

ABSTRACT

PURPOSE: The purpose of this analysis was to evaluate the potential of the tumor oxygenation by means of Eppendorf pO2 histography as a predictive test to select patients for treatment alternatives. PATIENTS AND METHODS: Pretreatment tumor pO2 histographies of locoregional lymph node metastases were assessed in 194 patients with squamous cell carcinoma of the head and neck. Included in the analysis were 134 patients who received a primary radio- or radiochemotherapy with a radiation dose of > or = 60 Gy, and who had no distant metastasis at beginning of the therapy. RESULTS: The Cox regression analysis revealed the fraction of pO2 values < or = 2.5 mm Hg (p = 0.004), age (p = 0.04) and radiotherapy/radiochemotherapy (p = 0.03) as significant independent prognostic factors for the survival. The positive and negative predictive values were calculated using different cut-off values of the fraction of pO2 values < or = 2.5 mm Hg and the survival status at 1 or 2 years after beginning of the therapy as endpoint. The highest positive and negative predictive values of all cut-off values were 0.50 and 0.41 at 1 year, and 0.81 and 0.26 at 2 years. CONCLUSIONS: Our data confirm the influence of the tumor oxygenation on the prognosis of patients with squamous cell carcinoma of the head and neck after radiotherapy. However, the calculated positive and negative predictive values suggest that the pO2 histography alone is not sufficient to be used as a predictive test to successfully select patients for treatment alternatives.


Subject(s)
Carcinoma, Squamous Cell/metabolism , Carcinoma, Squamous Cell/radiotherapy , Head and Neck Neoplasms/metabolism , Head and Neck Neoplasms/radiotherapy , Oxygen/metabolism , Sensitivity and Specificity , Adult , Aged , Aged, 80 and over , Carcinoma, Squamous Cell/mortality , Cell Hypoxia , Female , Head and Neck Neoplasms/mortality , Hemoglobins/analysis , Humans , Lymphatic Metastasis , Male , Middle Aged , Oxygen/analysis , Polarography , Predictive Value of Tests , Prognosis , Radiotherapy Dosage , Regression Analysis
6.
Lung Cancer ; 33 Suppl 1: S77-83, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11576711

ABSTRACT

Recent studies show that the presence of hypoxia is associated with poor local control and overall survival in patients with cervical cancer and head and neck cancer. An indirect support for the influence of hypoxia on radiation response is derived from observations of a correlation between tumor control and hemoglobin level. Most of the clinical studies have shown better tumor control in patients with higher hemoglobin levels than in patients with levels below normal range due to tumor associated or therapy-induced anemia. The problem of chemotherapy induced anemia is particularly of clinical relevance in patients with lung cancer. This manuscript reviews the clinical investigations in patients with lung cancer which have been performed with regard to improve tumor oxygenation increasing the amount of hemoglobin available to transport oxygen.


Subject(s)
Lung Neoplasms/metabolism , Lung Neoplasms/therapy , Oxygen/metabolism , Combined Modality Therapy , Hemoglobins/metabolism , Humans , Hypoxia/metabolism
7.
J Nucl Med ; 42(8): 1144-50, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11483672

ABSTRACT

UNLABELLED: The aim of this study was to evaluate the prognostic value of SPECT imaging using the amino acid analog 3-[(123)I]iodo-L-alpha-methyltyrosine (IMT) in patients with gliomas. METHODS: One hundred fourteen consecutive patients with newly diagnosed gliomas were examined by IMT SPECT (low-grade glioma, n = 12; anaplastic astrocytoma or oligodendroglioma, n = 46; glioblastoma, n = 56). Seventy-one of these patients had undergone tumor resection 4-6 wk before SPECT imaging (group A). Forty-three patients with unresectable tumors were examined after stereotactic biopsy (group B). IMT uptake at the site of the tumor was assessed visually and quantified relative to a contralateral reference region (IMT uptake ratio). After IMT SPECT, all patients were treated with conformal radiotherapy. The median follow-up time was 27 mo. RESULTS: In group A, focal IMT uptake at the resection site was visible in 52 of 71 patients (73%). Median survival was only 13 mo in these patients, whereas median survival was reached in patients without focal IMT uptake (P = 0.02). Furthermore, the intensity of IMT uptake significantly correlated with survival: patients with an IMT uptake ratio > 1.7 were at a 4.6 times higher risk of death than were patients with a lower IMT uptake (P < 0.001). The IMT uptake ratio remained a significant prognostic factor when age and grading were included in a multivariate model. In contrast, IMT uptake did not correlate with survival in group B (P = 0.95). CONCLUSION: In patients with unresectable high-grade gliomas, IMT uptake appears not to correlate with the biologic aggressiveness of tumor cells. Nevertheless, the clear association between focal IMT uptake after tumor resection and poor survival suggests that IMT is a specific marker for residual tumor tissue. Therefore, IMT SPECT is expected to become a valuable tool for the planning and monitoring of local therapeutic modalities.


Subject(s)
Brain Neoplasms/surgery , Glioma/surgery , Methyltyrosines , Radiopharmaceuticals , Adult , Brain Neoplasms/diagnostic imaging , Brain Neoplasms/radiotherapy , Combined Modality Therapy , Female , Glioma/diagnostic imaging , Glioma/radiotherapy , Humans , Male , Methyltyrosines/pharmacokinetics , Middle Aged , Prognosis , Radiopharmaceuticals/pharmacokinetics , Retrospective Studies , Survival Analysis , Tomography, Emission-Computed, Single-Photon
8.
Strahlenther Onkol ; 177(1): 25-32, 2001 Jan.
Article in German | MEDLINE | ID: mdl-11200109

ABSTRACT

PURPOSE: To evaluate overall survival, local tumor control and cosmetic outcome after breast-conserving surgery followed by radiotherapy without boost irradiation. PATIENTS AND METHODS: In a retrospective study 270 breast cancer patients were treated with breast conserving surgery combined with a homogenous radiation of the tumor bearing breast up to a total dose of 56 Gy without local boost irradiation. Mean follow-up was 48 months. Local tumor control, side effects, cosmetic results and contentment with treatment were assessed using physical examinations and interviews based on a standardized questionnaire. RESULTS: Cause-specific survival at 5 years after treatment was 88.3%, actuarial disease-free survival at 5 years was 76.1%. Within 23 to 78 months after treatment 12 patients suffered from ipsilateral breast recurrence. The actuarial freedom from local recurrence (single tumor manifestation) was 96.8% at 5 years after treatment, 89% at 10 years. The occurrence of local failures was not significantly correlated to tumor size, margins, grading, nodal status, age or lymphangiosis. 15.6% of the patients developed distant metastases. In all patients treatment was performed without interruption. Side effects were predominantly of mild degree, no severe side effects were detected. 73% of physicians and 81% of patients scored their cosmetic outcome as excellent or good. 93% of patients would again decide in favor of this procedure. Whereas use of adjuvant chemotherapy as well as subcutaneous reconstruction of breast tissue did not significantly affect breast cosmesis, analysis demonstrated impaired cosmetic results related to a larger breast size. CONCLUSION: The data of this study show that tumor control achieved by breast conserving surgery in combination with a radiation technique up to a total dose of 56 Gy which omits boost irradiation is within the range of literature data. Side effects of the therapy were tolerable. The treatment displayed a good compatibility with tolerable side effects and good cosmetic results.


Subject(s)
Breast Neoplasms/radiotherapy , Breast Neoplasms/surgery , Mastectomy, Segmental , Surgery, Plastic , Actuarial Analysis , Adult , Aged , Aged, 80 and over , Breast Neoplasms/mortality , Esthetics , Female , Follow-Up Studies , Humans , Mastectomy, Segmental/mortality , Middle Aged , Radiotherapy Dosage , Radiotherapy, Adjuvant , Retrospective Studies , Survival Rate , Time Factors
9.
Strahlenther Onkol ; 176(10): 458-61, 2000 Oct.
Article in German | MEDLINE | ID: mdl-11068590

ABSTRACT

BACKGROUND: Experimental and clinical studies have shown that a prolonged overall treatment time is associated with a decrease in local tumor control. METHODS: In a brief review, the clinical data of radiotherapy with split-course or treatment interruption were collected. RESULTS AND CONCLUSION: There was a detrimental effect of the treatment interruption on overall or disease-specific survival in patients with locally advanced head and neck cancer or non-small-cell lung cancer in particular in patients with good prognostic factors and well to moderate differentiated tumors. Therefore, interruption of radiotherapy in patients with curative treatment should be avoided.


Subject(s)
Carcinoma, Non-Small-Cell Lung/radiotherapy , Carcinoma, Squamous Cell/radiotherapy , Head and Neck Neoplasms/radiotherapy , Lung Neoplasms/radiotherapy , Carcinoma, Non-Small-Cell Lung/mortality , Carcinoma, Squamous Cell/mortality , Clinical Trials as Topic , Dose Fractionation, Radiation , Head and Neck Neoplasms/mortality , Humans , Lung Neoplasms/mortality , Multivariate Analysis , Prognosis , Radiotherapy Dosage , Retrospective Studies , Time Factors
10.
Strahlenther Onkol ; 176(10): 475-80, 2000 Oct.
Article in German | MEDLINE | ID: mdl-11068594

ABSTRACT

PURPOSE: Clinical investigation of a potential relationship between the polarographically measured tumor oxygenation and the p53 status in patients with squamous cell carcinoma of the head and neck. PATIENTS AND METHODS: In 99 patients with mostly advanced, histologically proven squamous cell carcinoma of the head and neck we estimated the classical tumor parameters (TNM stage, histological grading) the immunohistochemical p53-overexpression (DO-7) and the tumor oxygenation status (Eppendorf pO2 Histograph). The tumor volume and the hemoglobin concentration were evaluated simultaneously. RESULTS: No statistically significant difference could be detected between immunohistological p53-positive (p53 > or = 10% stained cells) and p53-negative tumors (p53 < 10% stained cells) regarding both the median pO2 and the relative frequency of values < or = 5 mm Hg. Moreover, no statistically relevant differences could be seen between both p53-groups considering the hemoglobin concentration, the TNM stage, the histological grading and the tumor volume. CONCLUSION: Our data imply that there is no association between p53-overexpression and tumor hypoxia in head and neck carcinomas. However, this is not necessarily in contradiction to experimental or clinical data that confirmed a relationship between hypoxia and p53-mediated increased malignancy of tumor cells in other tumor entities. The comparable oxygenation status of p53-positive and p53-negative tumors in our study is associated with an analogous clinical tumor aggressiveness of both groups. That could be caused by a hypoxia related but p53-independent selection of tumor cells with a more malignant phenotype in head and neck carcinomas. However, further research is needed to prove this possible relationship.


Subject(s)
Carcinoma, Squamous Cell/metabolism , Head and Neck Neoplasms/metabolism , Oxygen/metabolism , Tumor Suppressor Protein p53/metabolism , Adult , Aged , Aged, 80 and over , Carcinoma, Squamous Cell/genetics , Cell Hypoxia , Data Interpretation, Statistical , Female , Gene Expression Regulation, Neoplastic , Head and Neck Neoplasms/genetics , Humans , Immunohistochemistry , Male , Middle Aged , Polarography , Tumor Suppressor Protein p53/genetics
11.
Int J Biol Markers ; 15(3): 235-6, 2000.
Article in English | MEDLINE | ID: mdl-11012100

ABSTRACT

Hypoxic tumors of patients with squamous cell carcinoma of the head and neck show a consistent trend towards poor treatment outcome. We now report that tumor hypoxia in these patients is correlated with elevated antigen content of the tumor-associated serine protease uPA (urokinase-type plasminogen activator), a marker of tumor cell invasion and metastasis.


Subject(s)
Carcinoma, Squamous Cell/metabolism , Head and Neck Neoplasms/metabolism , Hypoxia/metabolism , Urokinase-Type Plasminogen Activator/biosynthesis , Carcinoma, Squamous Cell/pathology , Head and Neck Neoplasms/pathology , Humans , Neoplasm Invasiveness , Neoplasm Metastasis
12.
Eur J Nucl Med ; 27(5): 542-9, 2000 May.
Article in English | MEDLINE | ID: mdl-10853810

ABSTRACT

O-(2-[18F]Fluoroethyl)-L-tyrosine (FET) is a recently described amino acid analogue that has shown high accumulation in animal tumours. The aim of this study was to compare the uptake of FET with that of L-[methyl-11C]methionine (MET) in patients with suspected primary or recurrent intracerebral tumours. Sixteen consecutive patients with intracerebral lesions were studied on the same day by positron emission tomography (PET) using MET and FET. Uptake of FET and MET was quantified by standardized uptake values. Tracer kinetics for normal brain and intracerebral lesions were compared. On the basis of the MET-PET studies, viable tumour tissue was found in 13 patients. All tumours showed rapid uptake of FET and were visualized with high contrast. Mean uptake of FET for normal grey matter, white matter and tumour tissue was 1.1+/-0.2, 0.8+/-0.2 and 2.7+/-0.8 SUV, respectively. In all three tissues, uptake of MET was slightly higher (1.4+/-0.2, 0.9+/-0.1 and 3.3+/-1.0 SUV; P<0.01). However, contrast between tumour and normal tissues was not significantly different between MET and FET. Uptake of FET in non-neoplastic lesions (1.0+/-0.1 SUV) was significantly lower than in tumour tissue (P = 0.007). For all lesions there was a close correlation (r = 0.98) between MET and FET uptake. In conclusion, in PET studies of human brain tumours, the uptake and image contrast of FET appear to be very similar to those of MET. The specificity of FET for tumour tissue is promising but has to be addressed in a larger series of patients with non-neoplastic lesions.


Subject(s)
Brain Neoplasms/metabolism , Methionine/analogs & derivatives , Radiopharmaceuticals/pharmacokinetics , Tyrosine/analogs & derivatives , Adult , Aged , Brain Neoplasms/diagnostic imaging , Brain Neoplasms/surgery , Female , Fluorine Radioisotopes , Humans , Image Interpretation, Computer-Assisted , Image Processing, Computer-Assisted , Male , Methionine/pharmacokinetics , Middle Aged , Tomography, Emission-Computed , Tyrosine/pharmacokinetics
13.
Int J Radiat Oncol Biol Phys ; 47(2): 517-26, 2000 May 01.
Article in English | MEDLINE | ID: mdl-10802381

ABSTRACT

PURPOSE: This study compares the results of iodine-123-alpha-methyl-tyrosine single photon computed emission tomography (IMT-SPECT) with magnetic resonance imaging (MRI) in tumor volume definition of brain gliomas. Furthermore, it evaluates the influences of the information provided from IMT-SPECT for three-dimensional (3D) conformal treatment planning. METHODS AND MATERIALS: In 30 patients with nonresected, histologically proven brain gliomas (glioblastoma-13 patients, astrocytoma Grade III-12 patients, astrocytoma Grade II-3 patients, oligodendroglioma Grade III-1 patient, oligodendroglioma Grade II-1 patient), IMT-SPECT and MRI were performed pretherapeutically in the same week. A special software system allowed the coregistration of the IMT-SPECT and MRI data. The gross tumor volume (GTV) defined on the IMT-SPECT/T2-MRI fusion images (GTV-IMT/T2) was compared with the GTV-T2, defined on the T2-MRI alone. On the IMT-SPECT/T1Gd-MRI overlays, the volume of the IMT tumor uptake (GTV-IMT) was compared with the volume of the gadolinium (Gd) enhancement (GTV-T1Gd). The initial planning target volume (PTV) and the boost volume (BV) outlined on the IMT-SPECT/T2-MRI co-images were analyzed comparatively to the PTV and BV delineated using the T2-MRI alone. RESULTS: In all 30 patients a higher IMT uptake of tumor areas, compared to the normal brain tissue was observed. Mean GTV-IMT, mean GTV-T2, and mean GTV-T1Gd were 43, 82, and 16 cm(3), respectively. IMT tumor uptake outside the contrast enhancement regions was observed in all patients. Mean relative increase of tumor volume defined on the fusion images, GTV-IMT/T1Gd versus GTV-T1Gd alone was 78%. IMT tumor uptake areas outside the GTV-T2 were registered in 7 patients (23%). In these patients, the mean increase GTV-IMT/T2 was 33% higher than GTV-T2, defined according to the T2-MRI data alone. The additional information provided by IMT-SPECT modified minimally the initial PTV (mean relative increase PTV-IMT/T2 versus PTV-T2, 5%) but significantly the BV (mean relative increase BV-IMT/T2 versus BV-T2, 37%). CONCLUSION: In a significant number of patients, the IMT-SPECT investigation improves tumor detection and delineation in the planning process. This has important consequences in the 3D conformal treatment planning, especially in the delineation of BV and in dose escalation studies.


Subject(s)
Brain Neoplasms/diagnostic imaging , Glioma/diagnostic imaging , Methyltyrosines , Radiotherapy Planning, Computer-Assisted/methods , Tomography, Emission-Computed, Single-Photon/methods , Adult , Aged , Brain Neoplasms/diagnosis , Female , Glioma/diagnosis , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Radiotherapy, Conformal/methods
14.
Strahlenther Onkol ; 176(2): 67-72, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10697653

ABSTRACT

BACKGROUND: As the treatment with docetaxel in metastatic head and neck cancer resulted in an encouraging response rate, the following phase-I study examined the effects of a combined radiochemotherapy with weekly docetaxel in patients with inoperable advanced head and neck tumors. PATIENTS AND METHODS: Six patients with Stage IV head and neck cancer were included into the study. Within the treatment regimen the primary tumor and the involved lymph nodes were irradiated up to a total dose of 70 Gy, the non involved cervical and supraclavicular lymph nodes received 50 Gy in conventional fractionation. Simultaneously docetaxel was given 1 hour before radiotherapy. The initial dose was 15 mg/m2. RESULTS: A dose escalation was impossible because of several dose limiting toxicities (NCI-CTC) already in the first dose level. Two patients showed skin reactions Grade 4, 2 patients pulmonary complications Grade 4, 2 patient neurologic side effects Grade 3 and 1 a thrombocytopenia Grade 3. The response rate resulted in 3 complete and 1 partial remission, 1 death, 1 patient was not evaluable. CONCLUSION: Unexpectedly already in the first dose level several dose limiting toxicities were evaluated. For that reason the treatment scheme is not feasible.


Subject(s)
Antineoplastic Agents, Phytogenic/administration & dosage , Head and Neck Neoplasms/drug therapy , Head and Neck Neoplasms/radiotherapy , Paclitaxel/analogs & derivatives , Taxoids , Adult , Aged , Antineoplastic Agents, Phytogenic/adverse effects , Combined Modality Therapy , Docetaxel , Dose-Response Relationship, Drug , Female , Follow-Up Studies , Humans , Lymphatic Metastasis , Male , Middle Aged , Paclitaxel/administration & dosage , Paclitaxel/adverse effects , Radiotherapy Dosage , Time Factors , Treatment Outcome
15.
Int J Radiat Oncol Biol Phys ; 46(2): 459-66, 2000 Jan 15.
Article in English | MEDLINE | ID: mdl-10661354

ABSTRACT

PURPOSE: To investigate the relationship between tumor oxygenation and the blood hemoglobin (Hb) concentration in patients with squamous cell carcinoma of the head and neck (SCCHN). METHODS AND MATERIALS: A total of 133 patients with SCCHN underwent pretreatment polarographic pO2 measurements of their tumors. In 66 patients measurements were also made in sternocleidomastoid muscles. The patients were divided into three groups according to their Hb concentration-severe anemia (Hb < 11.0 g/dl), mild anemia (female: Hb 11.0-11.9 g/dl; male: Hb 11.0-12.9 g/dl), and normal Hb concentration (female: Hb > or =12.0 g/dl; male: > or =13.0 g/dl). RESULTS: No significant difference in tumor oxygenation could be detected between mildly anemic patients and patients with a normal Hb level. However, the tumor oxygenation in the severely anemic group was significantly below that of each of the other two groups (p < 0.0001). There was no significant difference between the Hb groups in oxygenation of sternocleidomastoid muscles. In a multivariate analysis including Hb group, tumor volume, smoking habits, gender, T-stage, N-stage, and histologic grade a Hb level < 11 g/dl was found to be the strongest predictor for a poor tumor oxygenation. Smoking also had a marginal influence on median pO2. CONCLUSION: Our data suggest that a low Hb concentration and cigarette smoking contribute to inadequate oxygenation of SCCHN and thus for increased radioresistance. Consequently, Hb correction and abstinence from smoking may significantly improve tumor oxygenation.


Subject(s)
Anemia/blood , Carcinoma, Squamous Cell/blood , Head and Neck Neoplasms/blood , Hemoglobin A/analysis , Oxygen/blood , Anemia/etiology , Blood Gas Monitoring, Transcutaneous , Female , Humans , Male , Middle Aged , Muscle, Skeletal/metabolism , Sex Factors
18.
Int J Radiat Oncol Biol Phys ; 44(4): 749-54, 1999 Jul 01.
Article in English | MEDLINE | ID: mdl-10386631

ABSTRACT

PURPOSE: Tumor hypoxia is regarded as an important factor influencing radiation response, disease-free, and overall survival of patients with squamous cell carcinoma of the head and neck (SCCHN). This study was performed to reevaluate the prognostic significance of the "classical oxygenation parameters" hypoxic fraction (percentage of pO2 values < 5 mmHg or < 2.5 mmHg, respectively) and median pO2, and to determine the influence of a new radiobiological factor. This factor was termed the "hypoxic subvolume" (HSV) and was defined as percentage of pO2-values below 5 mmHg multiplied by the total tumor volume. The rationale of this parameter was to quantify approximately the amount of hypoxic tissue which should be correlated to the number of hypoxic cells in the tumor. It is obvious that a tumor of 100 cm3 with a hypoxic fraction of 20% (HSV = 20 cm3) contains more hypoxic cells than a tumor of 1 cm3 with a hypoxic fraction of 50% (HSV = 0.5 cm3). METHODS AND MATERIALS: Pretreatment pO2 was assessed in 59 patients with SCCHN with the Eppendorf histograph, and pretreatment volume was determined by ultrasonography (lymphnode metastases) and computer tomography (primaries). All patients were referred to our departments for radiotherapy (n = 27, median dose 70 Gy) or radiochemotherapy (n = 32; 5-FU, mitomycin C, median dose 70 Gy), respectively. All parameters were evaluated using the Kaplan-Meier analysis, and significance was assumed at a p-value of < 0.05 (log-rank test, Cox-Mantel). A multivariate analysis was performed to control for confounding factors. The median follow-up was 233 days. At the time of the evaluation, 34 of the 59 patients were dead. RESULTS: In univariate analyses, the hypoxic fraction (pO2 < 5 mmHg, PO2 < 2.5 mmHg [p < 0.05]), the hemoglobin concentration (p < 0.05), and the hypoxic subvolume (p < 0.01) were of prognostic significance for overall survival. In multivariate analysis, the hemoglobin concentration and the hypoxic subvolume (p = 0.01) were significant prognosticators. We found no significant correlation between tumor volume or median pO2 and overall survival. No clear correlation was found between tumor volume and hypoxic fraction. CONCLUSION: These data suggest that the total amount of hypoxic tissue, as determined by the hypoxic subvolume, influences the prognosis of patients suffering from SCCHN. In addition, our data confirm the statements of previous studies that low pretherapy pO2-values indicate a worse prognosis.


Subject(s)
Carcinoma, Squamous Cell/radiotherapy , Cell Hypoxia/physiology , Head and Neck Neoplasms/radiotherapy , Analysis of Variance , Carcinoma, Squamous Cell/mortality , Carcinoma, Squamous Cell/pathology , Head and Neck Neoplasms/mortality , Head and Neck Neoplasms/pathology , Humans , Middle Aged , Oxygen Consumption , Prognosis , Radiotherapy Dosage
19.
Strahlenther Onkol ; 175(1): 1-9, 1999 Jan.
Article in English | MEDLINE | ID: mdl-9951511

ABSTRACT

PURPOSE: There is a large body of evidence suggesting that blood flow and oxygenation of human tumors are important research topics which may explain, in particular, resistance to radiation and to many antineoplastic drugs, which can limit the curability of solid tumors by radiotherapy and chemotherapy. MATERIALS AND METHODS: This manuscript reviews the clinical investigations which have been performed regarding blood flow and oxygenation status of human tumors in radiation oncology. RESULTS: The possible uses and limitations of the prognostic significance and the changes under therapy measuring blood flow and oxygenation in human tumors were discussed. In addition, several approaches were summarized, which can improve the microvascular O2 availability and perfusion-limited O2 delivery. CONCLUSION: The clinical data concerning the prognostic significance of blood flow, vascular function and oxygenation of human tumors are relevant for patient selection in clinical oncology. Strategies to improve traditional cancer therapy by modulation of the oxygenation status remain quite promising but more critical research and sophisticated clinical studies are necessary before its true potential is known.


Subject(s)
Neoplasms/blood supply , Neoplasms/metabolism , Neoplasms/radiotherapy , Oxygen/metabolism , Animals , Cell Hypoxia , Dose Fractionation, Radiation , Drug Resistance, Neoplasm , Female , Humans , Laser-Doppler Flowmetry , Magnetic Resonance Imaging , Male , Medical Oncology , Microcirculation , Neoplasms, Experimental/blood supply , Neoplasms, Experimental/metabolism , Patient Selection , Pilot Projects , Prognosis , Radiation Oncology , Radiotherapy Dosage , Rats , Research , Ultrasonography, Doppler, Color
20.
Ann Otol Rhinol Laryngol ; 108(1): 73-8, 1999 Jan.
Article in English | MEDLINE | ID: mdl-9930544

ABSTRACT

This study explored patterns of oxygen distribution in human tumors during primary radiochemotherapy. Patients with positive nodes from head and neck squamous cell carcinoma (n = 15) were investigated before therapy, before and after a 2-week respite, and at the end of the treatment. Intratumoral tissue oxygen tension (pO2) was measured with sterile polarographic needle electrodes and a computerized histography system. The 2 lowest pO2 classes, ie, 0 and 5 mm Hg, were designated the hypoxic fraction, and the mean and median pO2 were evaluated for each tumor. In the beginning, a marked variability in tissue pO2 was found. The initial size of the hypoxic fraction ranged from 0% to 61% of measured values. At the end of treatment, 4 tumors showed an increase in mean pO2, and 7 tumors a lower mean pO2 in comparison to the initial values. However, an impressive finding was that the hypoxic fraction of 9 tumors became smaller during the pause, 1 tumor showed no change, and 1 showed an increase in hypoxic fraction. The results show that there is a widely distributed tissue oxygenation with marked hypoxic zones in human neck nodes. During radiochemotherapy, tissue oxygenation changed, with great intertumor variability. A tendency toward a decrease of the hypoxic fraction after the respite could be seen. This change in tumor oxygenation during therapy needs further evaluation.


Subject(s)
Carcinoma, Squamous Cell/drug therapy , Carcinoma, Squamous Cell/radiotherapy , Head and Neck Neoplasms/metabolism , Head and Neck Neoplasms/therapy , Hypoxia/diagnosis , Oxygen/metabolism , Adult , Aged , Aged, 80 and over , Dose Fractionation, Radiation , Dose-Response Relationship, Radiation , Female , Humans , Hypoxia/complications , Male , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL
...